These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21986062)

  • 1. [Protection from pulmonary apoptosis: a new therapeutic choice for septic acute lung injury].
    Takano K; Oishi H; Hattori Y
    Nihon Yakurigaku Zasshi; 2011 Oct; 138(4):146-50. PubMed ID: 21986062
    [No Abstract]   [Full Text] [Related]  

  • 2. Olprinone and colforsin daropate alleviate septic lung inflammation and apoptosis through CREB-independent activation of the Akt pathway.
    Oishi H; Takano K; Tomita K; Takebe M; Yokoo H; Yamazaki M; Hattori Y
    Am J Physiol Lung Cell Mol Physiol; 2012 Jul; 303(2):L130-40. PubMed ID: 22610350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins in patients with sepsis and ARDS: is it over? Yes.
    Alhazzani W; Truwit J
    Intensive Care Med; 2017 May; 43(5):672-674. PubMed ID: 27752735
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins in patients with sepsis and ARDS: is it over? No.
    Kruger PS; Terblanche M
    Intensive Care Med; 2017 May; 43(5):675-676. PubMed ID: 27752737
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of acute lung injury with pitavastatin in septic mice: potential role of glucocorticoid receptor expression in alveolar macrophages.
    Takano K; Yamamoto S; Tomita K; Takashina M; Yokoo H; Matsuda N; Takano Y; Hattori Y
    J Pharmacol Exp Ther; 2011 Feb; 336(2):381-90. PubMed ID: 21057058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [GRK2 as a potential therapeutic target for septic ARDS].
    Ohashi W; Hattori Y
    Nihon Yakurigaku Zasshi; 2015 Mar; 145(3):122-8. PubMed ID: 25765493
    [No Abstract]   [Full Text] [Related]  

  • 7. Simvastatin as a potential therapeutic for acute respiratory distress syndrome.
    Fessler MB
    Am J Respir Crit Care Med; 2009 Nov; 180(10):1031; author reply 1031-2. PubMed ID: 19897776
    [No Abstract]   [Full Text] [Related]  

  • 8. Rosuvastatin for sepsis-associated ARDS.
    Leaf DE; Waikar SS
    N Engl J Med; 2014 Sep; 371(10):968. PubMed ID: 25184877
    [No Abstract]   [Full Text] [Related]  

  • 9. Rosuvastatin for sepsis-associated ARDS.
    Liu KD; Dong N; Truwit JD
    N Engl J Med; 2014 Sep; 371(10):968-9. PubMed ID: 25184876
    [No Abstract]   [Full Text] [Related]  

  • 10. Statin strikeout.
    Drazen JM; Gelijns AC
    N Engl J Med; 2014 Jun; 370(23):2240-1. PubMed ID: 24835850
    [No Abstract]   [Full Text] [Related]  

  • 11. Statins exposure and delirium risk: a winning association?*.
    Casarin A; McAuley DF; Page VJ
    Crit Care Med; 2014 Aug; 42(8):1955-7. PubMed ID: 25029141
    [No Abstract]   [Full Text] [Related]  

  • 12. Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: reversal effect of fluvastatin therapy.
    Matsuda N; Hayashi Y; Takahashi Y; Hattori Y
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1348-54. PubMed ID: 17003232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 2014 American Thoracic Society International Conference.
    Kang S
    Lancet Respir Med; 2014 Jul; 2(7):518-20. PubMed ID: 25140364
    [No Abstract]   [Full Text] [Related]  

  • 14. HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells.
    Skaletz-Rorowski A; Lutchman M; Kureishi Y; Lefer DJ; Faust JR; Walsh K
    Cardiovasc Res; 2003 Jan; 57(1):253-64. PubMed ID: 12504836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting Abl kinases to regulate vascular leak during sepsis and acute respiratory distress syndrome.
    Rizzo AN; Aman J; van Nieuw Amerongen GP; Dudek SM
    Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1071-9. PubMed ID: 25814671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of the phosphoinositide 3-kinase pathway alters innate resistance to polymicrobial sepsis.
    Williams DL; Li C; Ha T; Ozment-Skelton T; Kalbfleisch JH; Preiszner J; Brooks L; Breuel K; Schweitzer JB
    J Immunol; 2004 Jan; 172(1):449-56. PubMed ID: 14688354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of pulmonary microvascular endothelial cell apoptosis in murine sepsis-induced lung injury in vivo.
    Gill SE; Rohan M; Mehta S
    Respir Res; 2015 Sep; 16(1):109. PubMed ID: 26376777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airway and lung in sepsis.
    Martin GS; Bernard GR;
    Intensive Care Med; 2001; 27 Suppl 1():S63-79. PubMed ID: 11307371
    [No Abstract]   [Full Text] [Related]  

  • 19. Total ginsenosides synergize with ulinastatin against septic acute lung injury and acute respiratory distress syndrome.
    Sun R; Li Y; Chen W; Zhang F; Li T
    Int J Clin Exp Pathol; 2015; 8(6):7385-90. PubMed ID: 26261640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoration of alveolar type II cell function contributes to simvastatin-induced attenuation of lung ischemia-reperfusion injury.
    Wu Y; Lv J; Feng D; Jiang F; Fan X; Zhang Z; Yin R; Xu L
    Int J Mol Med; 2012 Dec; 30(6):1294-306. PubMed ID: 23076613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.